AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 295: R906-R915, 2008. First published June 25, 2008; doi:10.1152/ajpregu.00164.2008
0363-6119/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/3/R906    most recent
00164.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Julian, C. G.
Right arrow Articles by Moore, L. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Julian, C. G.
Right arrow Articles by Moore, L. G.

DEVELOPMENTAL PHYSIOLOGY AND PREGNANCY

Lower uterine artery blood flow and higher endothelin relative to nitric oxide metabolite levels are associated with reductions in birth weight at high altitude

Colleen Glyde Julian,1,2 Henry L. Galan,3 Megan J. Wilson,1,2 Wendy DeSilva,1 Darleen Cioffi-Ragan,3 Joel Schwartz,3 and Lorna G. Moore1,2

1Altitude Research Center, Department of Surgery, Division of Emergency Medicine, 2Department of Health and Behavioral Sciences, 3Department of Obstetrics and Gynecology, University of Colorado Denver, Aurora, Colorado

Submitted 4 March 2008 ; accepted in final form 10 June 2008

Reduced uteroplacental blood flow is hypothesized to play a key role in altitude-associated fetal growth restriction. It is unknown whether reduced blood flow is a cause or consequence of reduced fetal size. We asked whether determinants of uteroplacental blood flow were altered prior to reduced fetal growth and whether vasoactive and/or angiogenic factors were involved. Women residing at low (LA; 1600 m, n = 18) or high altitude (HA; 3100 m, n = 25) were studied during pregnancy (20, 30, and 36 wk) and 4 mo postpartum (PP) using Doppler ultrasound. In each study, endothelin (ET-1), nitric oxide metabolites (NOx), soluble fms-like tyrosine kinase (sFlt-1) and placental growth factor (PlGF) levels were quantified. At HA, birth weights were lower (P < 0.01) and small-for-gestational age was more common (P < 0.05) compared with LA. HA was associated with lower uterine artery (UA) diameter (P < 0.01) and blood flow (P < 0.05). Altitude did not affect ET-1, sFlt-1 or PlGF; however, ET-1/NOx was greater and NOx lower during pregnancy and PP at HA vs. LA. ET-1/NOx was negatively associated with birth weight (20 wk, P < 0.01; 36 wk, P = 0.05) at LA and HA combined. At HA, UA blood flow (30 wk) was positively associated with birth weight ({dagger}). UA blood flow and ET-1/NOx levels accounted for 45% (20 wk) and 32% (30 wk) of birth weight variation at LA and HA combined, primarily attributed to effects at HA. We concluded that elevated ET-1/NOx and altered determinants of uteroplacental blood flow occur prior to altitude-associated reductions in fetal growth, and therefore, they are likely a cause rather than a consequence of smaller fetal size.

fetal growth restriction; hypoxia; small-for-gestational age; uteroplacental oxygen delivery; pregnancy



Address for reprint requests and other correspondence: C. Glyde Julian, Altitude Research Center, Dept. of Surgery, Division of Emergency Medicine, Univ. of Colorado Denver, 12469 East 17th Place, Bldg. 400, Aurora, Colorado 80045 (e-mail: colleen.julian{at}uchsc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.